09 May Celebrating Mother’s Day with good health
Posted at 17:18h in News
The Seattle Times
I was thrilled to learn that the U.S. Food and Drug Administration, FDA, announced that the Novartis drug Afinitor (Everolimus) has been approved for the treatment of advanced pancreatic-neuroendocrine tumors [“Medical digest,” News, April 13].
Pancreatic-neuroendocrine tumors make up less than 5 percent of all pancreatic-cancer diagnoses and are generally slower growing and less aggressive than the more common form of pancreatic cancer, pancreatic adenocarcinoma.